Summary A total of 80 primary human breast carcinoma DNAs were analysed for loss of heterozygosity (LOH) on the long arm of chromosome 6, using microsatellite markers whose location has been defined physically and by linkage analysis. Loss of heterozygosity was observed in 38 of 80 (48%) tumours that were informative for at least one locus. The analysis revealed partial or interstitial deletions of chromosome 6q. Detailed mapping of chromosome 6q in these tumour DNAs identified two and perhaps three commonly deleted regions. One of these is located between markers D6S251 and D6S252 (6q14 -q16.2), another between D6S268 and D6S261 (6q 16.3 -q23) and a third between D6S287 and D6S270 (6q22.3 -q23. 1).
Cytogenetic (Dutrillaux et al., 1990; Lu et al., 1993; Thompson et al., 1993; Trent et al., 1985 Trent et al., , 1993 and molecular analyses (reviewed in Callahan et al., 1993) of primary human breast carcinomas have documented frequently occurring genetic alterations that take place during the evolution of tumour development. It is thought that these mutations either inactivate normal growth controls or give the tumour some selective advantage. At the molecular level, loss of heterozygosity (LOH) is the most frequent type of genetic alteration in primary human breast tumours . LOH at specific chromosomal loci has been taken as evidence for the presence of putative tumour-suppressor genes within the affected regions (Knudson, 1989) . In sporadic primary human breast carcinomas LOH has been detected on at least 12 different chromosome arms . However only in the case of chromosome l7pl3 has the target gene for LOH (TP53) been identified (Hollstein et al., 1991) . Generally one allele of the target gene is lost and the remaining allele contains a nonsense or missense mutation. The involvement of chromosome 6q in breast carcinomas has been noted in cytogenetic analysis of primary tumours (Dutrillaux et al., 1990; Lu et al., 1993; Thompson et al., 1993; Trent et al., 1985 Trent et al., , 1993 . Similarly, molecular analysis of primary breast tumour DNAs has shown that chromosome 6q is frequently affected by LOH (Devilee et al., 1991) . In this report, we describe studies aimed at defining the location of putative tumour-suppressor gene(s) on chromosome 6q in primary breast tumour DNAs. We have screened 80 pairs of matched breast tumour and normal DNAs using sequence-tag sites (STSs) whose location has been defined by linkage analysis and have constructed a detailed deletion map of this chromosome arm. Table I . The PCR products were diluted with loading buffer (95% formamide, 20 mM EDTA, 0.05% bromophenol blue and 0.05% xylene cyanol), heat denatured and rapidly cooled. Samples were run in pairs (tumour and lymphocyte PCR product from the same patient) on a denaturing gel (7% acrylamide, 32% formamide, 6 M urea, 1 x TBE) at a constant 30-35 W. After electrophoresis the gel was transferred to 3MM Whatman paper and autoradiography performed with Kodak X-Omat AR film at -70'C. When the signal of an allele in tumour DNA was less than 50% of intensity observed in matching normal DNA from a heterozygous patient, LOH was considered to have occurred (Bieche et al., 1993) .
Materials and methods

Results
Preliminary results obtained at 6 loci (D6S254, D6S251, D6S252, D6S249, ARGI and D6S255) on chromosome 6q in 30 breast tumour DNAs (tumour panel 1) suggested that LOH on this arm of chromosome 6 was a frequent event (Table II) The genotypes of nine tumour DNA samples from tumour panel 1 at STS markers between D6S254 and D6S255 that were tested and their regional locations are listed. The genetic order of the STS loci is according to published linkage studies (Gyapa et al., 1994; Volz et al., 1994) . n, total number of tumour DNA samples examined for each marker; LOH/inf., fraction of tumours from informative patients that showed LOH at each marker; the number in parenthesis is the percentage of tumours having LOH at each locus; D, LOH; H, STS loci that were informative but unaffected; NI, STS loci that were not informative.
tion and order were determined by linkage analysis (Gyapa et al., 1994; Volz et al., 1994) . In this second set of 50 breast tumour DNA samples, all were informative for at least one locus and of these 29 (58%) had LOH at one or more loci. The frequency of LOH at the different STSs loci on chromosome 6q for tumour panel 2 is shown in Table III . Autoradiographs of two tumour DNA samples from tumour panel 2, each at three different STS loci, is shown in Figure 1 . Sample 281 had LOH at D6S286 and D6S251 but was informative and unaffected at D6S252. These results taken together with those summarised in Table  III for Shown in Figure 1 are autoradiographs of tumour DNA sample 82, which indicate that a second region of chromosome 6q is independently affected by LOH. In this tumour DNA, D6S268 and D6S261 are both informative and unaffected whereas LOH was detected at D6S302. The results summarised in Table III for tumour DNA samples 63, 224 and 204 are also consistent with the presence of a tumoursuppressor gene located in the 5.2 cM interval between D6S268 and D6S261 (region 2). Evidence for a third region affected by LOH was found in tumours DNAs 204, 99, 208, 49, 114 and 83 (Table III) . In these tumour DNA samples D6S262 was affected by LOH, whereas the more centromeric locus D6S287 was informative and unaffected. The telomeric boundary of this region could be D6S270 since in tumour DNAs 204 and 99 it was unaffected by LOH.
Several of the tumour DNAs were remarkable in that more than one region of chromosome 6q was affected by LOH. For instance tumour DNA samples 82, 263 and 281 exibited independent LOH of regions 1 and 2 whereas in tumour DNA 204 regions 2 and 3 were independently affected by LOH (Table III) (Gyapa et al., 1994; Volz et al., 1994) the second functional region is located between the CNR locus (6ql4-ql5) and D6S310 (9 cM telomenrc of D6S270, see Table III ). This second functional region is consistent with regions 1, 2 and possibly 3 presented in our study. Clearly the development of a physical map of the polymorphic STSs loci on chromosome 6q should lead to further definition of the regions affected by LOH and to the target gene(s) in primary breast tumours.
